Page last updated: 2024-10-25

damnacanthal and Neoplasms

damnacanthal has been researched along with Neoplasms in 1 studies

damnacanthal: structure given in first source; isolated from the stem bark and roots of Morinda lucida; a selective inhibitor of p56(lck) tyrosine kinase activity

Neoplasms: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Research Excerpts

ExcerptRelevanceReference
"Damnacanthal was shown to inhibit the oncogene Ras, p56lck tyrosine kinase, NF-KB pathway and induce apoptosis in vitro."2.50Damnacanthal: a promising compound as a medicinal anthraquinone. ( Abu, N; Ali, NM; Alitheen, NB; Aziz, MY; Ho, WY; Yeap, SK, 2014)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abu, N1
Ali, NM1
Ho, WY1
Yeap, SK1
Aziz, MY1
Alitheen, NB1

Reviews

1 review available for damnacanthal and Neoplasms

ArticleYear
Damnacanthal: a promising compound as a medicinal anthraquinone.
    Anti-cancer agents in medicinal chemistry, 2014, Volume: 14, Issue:5

    Topics: Anthraquinones; Antineoplastic Agents; Apoptosis; Cell Movement; Humans; Morinda; Neoplasms; Photose

2014